Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Nitric oxide releasing derivatives of paracetamol patented

April 14, 2009

KAI initiates third phase IIa KAI-1678 trial for neuropathic pain

April 9, 2009

IntelGenx and Cary file NDA for antidepressant, CPI-300

April 9, 2009

Amarin's MAA for AMR-101 in Huntington's disease accepted for review

April 9, 2009

Somaxon provides update on NDA for Silenor for insomnia

April 9, 2009

Avineuro commences phase I AVN-101 study for Alzheimer's disease

April 9, 2009

Novel inhibitors of Abeta calcium channel activity confer neuroprotection in vitro

April 9, 2009

Schering-Plough patent discloses novel gamma-secretase modulators for the treatment of AD

April 9, 2009

FDA Advisory Committee provides opinion on Serdolect in schizophrenia

April 8, 2009

Aplenzin extended-release tablets available in the U.S.

April 8, 2009

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...